Login
Companies $TEM
$67.06 +$2.30 (3.55%) After hours

What Do They Do?

Provides laboratory tests that connect results with patients’ clinical data, using artificial intelligence to help physicians tailor care, and licenses de-identified health data and clinical-trial support to pharmaceutical and biotechnology companies.

How Do They Make Money?

For clinical tests, Tempus is paid by Medicare, Medicaid and commercial insurers after claims are processed, generally 30-120 days after service; direct-bill customers usually pay 30-60 days after invoice. Drug and biotechnology customers pay for data licenses and clinical-trial services, generally 60 to 90 days after service.

revenue
SegmentShareRevenue
Diagnostics
Sold outright

75%
Data and applications
25%

Who Are Their Customers?

Healthcare providers order laboratory tests, with clinical testing billed to insurers and government programs; research institutions and other parties can pay directly for tests. Pharmaceutical and biotechnology companies also buy licensed data and clinical-trial services.

Do Revenues Turn Into Profits?

No. It lost $245M in FY2025.

Operating income, FY2025
−20% of revenue
▲ +63% (Loss) vs FY2024 (−$691.1M, −100%)
Net income, FY2025
−19% of revenue
▲ +65% (Loss) vs FY2024 (−$705.8M, −102%)
Free cash flow, FY2025
−19% of revenue
▼ −13% (Loss) vs FY2024 (−$211.2M, −30%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +23%
vs $334.2M in Q3 FY2025
Net income
▲ +81% (Loss)
vs −$80M in Q3 FY2025
Diagnostics share of revenue vs 75.7% in Q3 FY2025
  • Jul 30, 2026 Raised 2026 revenue guidance The company raised its full-year 2026 revenue range to $1.595 to $1.605 billion.
  • Jul 20, 2026 Agreed to acquire Personalis
Revenue over time
Diagnostics Data and applications
$2B$1B$0

Who Do They Compete With?

Competes with Foundation Medicine, Roche Holdings, Caris Life Sciences, Guardant Health, Natera, Neogenomics, ResolutionBio, Agilent, Quest, LabCorp, Myriad Genetics, Genomind, GeneDx, Variantyx, Baylor Genetics, Flatiron Health, IQVIA Holdings, ConcertAI, Fortrea, and ICON

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support